The short-term effect of hyperoncotic albumin, given alone or with furosemide, on oxygenation in sepsis-induced acute respiratory distress syndrome

Anaesthesia

Volumn 62, Issue 3, 2007, Pages 259-263

  Kuper, M ^a   Gunning, M P ^b   Halder, S ^c   Soni, N ^c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; HUMAN ALBUMIN; UNCLASSIFIED DRUG; ZENALB; ALBUMINOID; DIURETIC AGENT; HYPERONCOTIC ALBUMIN; OXYGEN; PLASMA SUBSTITUTE; SERUM ALBUMIN;

AGED; ALBUMIN BLOOD LEVEL; ARTERIAL OXYGEN TENSION; ARTICLE; BOLUS INJECTION; CASE STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; MALE; MONOTHERAPY; OXYGENATION; RESPIRATORY DISTRESS; SEPSIS; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; BLOOD; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PRESSURE; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ALBUMINS; COMBINED MODALITY THERAPY; DIURETICS; FEMALE; FUROSEMIDE; HUMANS; MALE; MIDDLE AGED; OXYGEN; PARTIAL PRESSURE; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 34047144877     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.04941.x     Document Type: Article

References (12)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; ii: 319-23.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine 1994; 149: 818-24.
3. Margarson MP, Soni NC. Effects of albumin supplementation on microvascular permeability in septic patients. Journal of Applied Physiology 2002; 92: 2139-45.
4. Bone RC. Treatment of adult respiratory distress syndrome with diuretics, dialysis, and positive end-expiratory pressure. Critical Care Medicine 1978; 6: 136-9.
5. Geer RT, Soma LR, Barnes C, Leatherman JL, Marshall BE. Effects of albumin and/or furosemide therapy on pulmonary edema induced by hydrochloric acid aspiration in rabbits. Journal of Trauma 1976; 16: 788-91.
6. Martin GS, Mangialardi RJ, Wheeler AP, et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Critical Care Medicine 2002; 30: 2175-82.
7. Martin GS, Moss M, Wheeler AP, et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Critical Care Medicine 2005; 33: 1681-7.
8. Margarson MP, Soni NC. Changes in serum albumin concentration and Volume expanding effects following a bolus of albumin 20% in septic patients. British Journal of Anaesthesia 2004; 92: 821-6.
9. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101: 1481-3.
10. Quinlan GJ, Mumby S, Martin GS, et al. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Critical Care Medicine 2004; 32: 755-9.
11. Gattinoni L, Caspani ML. Albumin and furosemide in acute lung injury: A little step forward? Critical Care Medicine 2002; 30: 2376-7.
12. Martin GS, Eaton S, Mealer M, Moss M. Extravascular lung water in patients with severe sepsis: A prospective cohort study. Critical Care 2005; 9: R74-82.